Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation
- DOI
- 10.1097/ftd.0000000000001176
- Published
- 2024-05-15
- Container
- Therapeutic Drug Monitoring
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/ftd.0000000000001176,
title = {Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation},
author = {Eun Sil Kim and Hyangah Chon and Yiyoung Kwon and Misook Lee and Mi Jin Kim and Yon Ho Choe},
year = {2024},
journal = {Therapeutic Drug Monitoring},
doi = {10.1097/ftd.0000000000001176},
url = {https://doi.org/10.1097/ftd.0000000000001176}
}RIS
TY - JOUR TI - Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation AU - Eun Sil Kim AU - Hyangah Chon AU - Yiyoung Kwon AU - Misook Lee AU - Mi Jin Kim AU - Yon Ho Choe PY - 2024 JO - Therapeutic Drug Monitoring DO - 10.1097/ftd.0000000000001176 UR - https://doi.org/10.1097/ftd.0000000000001176 ER -
APA
Kim, E. S., Chon, H., Kwon, Y., Lee, M., Kim, M. J., & Choe, Y. H. (2024). Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation. Therapeutic Drug Monitoring. https://doi.org/10.1097/ftd.0000000000001176
Source records
- crossref · retrieved 2026-09-27T16:19:01.514Z